Servier India has tied up with MedGenome and Reliance-backed Strand Life Sciences to offer low-cost IDH1 and IDH2 biomarker testing for rare cancers like AML and CCA across India
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
